On April 12, Friends of Cancer Research held a briefing on Capitol Hill on the topic of Breakthrough Therapy Designation: Successes, Lessons Learned and Future Strategies. Through the breakthrough therapy program, which followed the passage of the Food and Drug Administration Safety and Innovation Act (FDASIA) in 2012, a new drug may be designated as […]
Today, a bi-partisan bill called the “21st Century Cures,” which would add $8.5 billion of funding to the NIH’s budget, passed by a 344-77 vote in the House.
The bill seeks to “accelerate the discovery, development and delivery of life saving and life improving therapies, and transforms the quest for faster cures by:
Removing barriers to increased research […]